Article
During AMCP Nexus, we spoke to Beckie Fenrick, pharmacy practice leader at Stoney Hill Partners and Cambridge Advisory Group, about 340B, copay cards, integrating the pharmacy and medical benefits, and potential problems regarding site-of-service optimization. Listen to the audio now!
During AMCP Nexus, we spoke to Beckie Fenrick, pharmacy practice leader at Stoney Hill Partners and Cambridge Advisory Group, about 340B, copay cards, integrating the pharmacy and medical benefits, and potential problems regarding site-of-service optimization. Listen to the audio now!
jwplayer('container01').setup({ playlist: [{ sources: [{ file: "/_media/_mp3/BeckieFenrickEDITED.mp3" }] }], height: 30, primary: "flash", 'autostart': 'false', width: 320 });
FDA Approves Bimekizumab-Bkzx as Treatment for Hidradenitis Suppurativa